INTEC PHARMA LTD. Deferred Tax Assets, Operating Loss Carryforwards
INTEC PHARMA LTD. had Deferred Tax Assets, Operating Loss Carryforwards of $39.92 million as of 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2021-03-16
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards $39.92M.
- 2019-12-31: Deferred Tax Assets, Operating Loss Carryforwards $33.32M.
- 2018-12-31: Deferred Tax Assets, Operating Loss Carryforwards $24.74M.
- 2017-12-31: Deferred Tax Assets, Operating Loss Carryforwards $17.98M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2020-12-31 | $39.92M 10-K · filed 2021-03-16 |
| 2019-12-31 | $33.32M 10-K · filed 2021-03-16 |
| 2018-12-31 | $24.74M 10-K · filed 2020-03-13 |
| 2017-12-31 | $17.98M 10-K · filed 2019-02-27 |